Breaking News Instant updates and real-time market news.

IONS

Ionis Pharmaceuticals

$67.35 /

+0.215 (+0.32%)

, BIIB

Biogen

$229.80 /

+0.75 (+0.33%)

13:01
05/24/19
05/24
13:01
05/24/19
13:01

Ionis, Biogen slip after FDA approves Novartis' Zolgensma for SMA treatment

Shares of Ionis Pharmaceuticals (IONS) and Biogen (BIIB) are both moving lower in afternoon trading after Novartis (NVS) announced that Zolgensma was just approved by the FDA for the treatment of pediatric patients less than 2 years of age with spinal muscular atrophy, or SMA, with bi-allelic mutations in the survival motor neuron 1 gene. Morgan Stanley analyst Matthew Harrison previously has noted that Biogen's Spinraza had been the only approved drug for SMA and represents 17% of Biogen's estimated 2019 sales. Ionis receives royalties from Biogen for Spinraza. Harrison's base case assumption is that Zolgensma will ultimately capture the majority market share in type 1 patients and a "significant portion" of type 2, or pediatric, patients, he has told investors in a prior research note. Following the announcement of the FDA approval of Zolgensma, Ionis shares are down $1.83, or 3%, to $65.31, while Biogen shares are down $1.55, or 0.7%, to $227.56.

IONS

Ionis Pharmaceuticals

$67.35 /

+0.215 (+0.32%)

BIIB

Biogen

$229.80 /

+0.75 (+0.33%)

NVS

Novartis

$87.21 /

+2.75 (+3.26%)

  • 29

    May

  • 31

    May

  • 05

    Jun

  • 06

    Jun

  • 17

    Jun

  • 18

    Jun

IONS Ionis Pharmaceuticals
$67.35 /

+0.215 (+0.32%)

05/24/19 Piper Sandler
Piper 'incrementally more positive' on Ionis after management meetings
05/09/19 Piper Sandler
Ionis Pharmaceuticals shares 'more interesting on pullback', says Piper Jaffray
05/07/19 Morgan Stanley
Biogen could rise, or fall, 5% based on Zolgensma label, says Morgan Stanley
05/07/19 Piper Sandler
Piper more confident in estimates for Alnylam's Onpattro after doctor survey
BIIB Biogen
$229.80 /

+0.75 (+0.33%)

05/23/19
Biogen initiated with a Neutral at Wedbush
05/22/19
Citi assumes coverage of large-cap biotech, upgrades Amgen and Gilead
05/22/19 Wedbush
Biogen initiated with a Neutral at Wedbush
05/20/19 Credit Suisse
Biogen initiated with an Underperform at Credit Suisse
NVS Novartis
$87.21 /

+2.75 (+3.26%)

05/20/19 Credit Suisse
Regeneron initiated with a Neutral at Credit Suisse
05/20/19 RBC Capital
RBC says posting hints at Zolgensma label potentially positive for PTC, Biogen
05/17/19 Credit Suisse
Alcon off to 'solid start' post-Novartis spin, says Credit Suisse
05/13/19 Wells Fargo
Lawsuit against Teva, others to hit generic drug stocks, says Wells Fargo

TODAY'S FREE FLY STORIES

Recommendations
Rigel's Tavalisse shown effective for COVID lung injury, says Citi » 08:37
07/13/20
07/13
08:37
07/13/20
08:37
RIGL

Rigel Pharmaceuticals

$1.78 /

-0.04 (-2.20%)

A new study out of MIT…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RIGL Rigel Pharmaceuticals
$1.78 /

-0.04 (-2.20%)

RIGL Rigel Pharmaceuticals
$1.78 /

-0.04 (-2.20%)

08:30 Today Citi
Study points to possible role for Rigel in treating COVID injury, says Citi
02/27/20 Piper Sandler
Piper Sandler continues to like Rigel Pharmaceuticals setup
01/16/20 H.C. Wainwright
Rigel launch of Tavalisse remains encouraging, says H.C. Wainwright
01/13/20 Piper Sandler
Rigel still one of the most under-appreciated stories in sector, says Piper
RIGL Rigel Pharmaceuticals
$1.78 /

-0.04 (-2.20%)

RIGL Rigel Pharmaceuticals
$1.78 /

-0.04 (-2.20%)

Hot Stocks
Nexstar transfers option to buy E.W. Scripps' CW affiliate WPIX to Mission » 08:37
07/13/20
07/13
08:37
07/13/20
08:37
NXST

Nexstar

$79.90 /

+3.89 (+5.12%)

, SSP

E.W. Scripps

$8.90 /

+0.69 (+8.40%)

The E.W. Scripps Company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NXST Nexstar
$79.90 /

+3.89 (+5.12%)

SSP E.W. Scripps
$8.90 /

+0.69 (+8.40%)

NXST Nexstar
$79.90 /

+3.89 (+5.12%)

06/22/20 Benchmark
Nexstar price target raised to $125 from $120 at Benchmark
05/07/20 Wells Fargo
Nexstar price target raised to $88 from $81 at Wells Fargo
05/07/20 B. Riley FBR
Nexstar price target raised to $115 from $110 at B. Riley FBR
05/05/20 B. Riley FBR
Nexstar price target lowered to $110 from $139 at B. Riley FBR
SSP E.W. Scripps
$8.90 /

+0.69 (+8.40%)

07/07/20
Stitcher would help Sirius 'future-proof' business, says B. Riley FBR
06/25/20 Benchmark
Benchmark sees material benefits if E.W. Scripps sells Stitcher
03/03/20 Wells Fargo
Disney price target lowered to $155 from $180 at Wells Fargo
12/11/19 Guggenheim
Guggenheim says Nexstar, Gray best positioned for 'record' political cycle
NXST Nexstar
$79.90 /

+3.89 (+5.12%)

SSP E.W. Scripps
$8.90 /

+0.69 (+8.40%)

SSP E.W. Scripps
$8.90 /

+0.69 (+8.40%)

SSP E.W. Scripps
$8.90 /

+0.69 (+8.40%)

Hot Stocks
Adverum Biotechnologies randomizes first patient in Phase 2 INFINITY trial » 08:36
07/13/20
07/13
08:36
07/13/20
08:36
ADVM

Adverum Biotechnologies

$19.90 /

-1.18 (-5.60%)

Adverum Biotechnologies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADVM Adverum Biotechnologies
$19.90 /

-1.18 (-5.60%)

ADVM Adverum Biotechnologies
$19.90 /

-1.18 (-5.60%)

07/08/20 Cantor Fitzgerald
Adverum Biotechnologies price target raised to $36 from $21 at Cantor Fitzgerald
06/29/20 Piper Sandler
Adverum Biotechnologies should be bought on selloff, says Piper Sandler
06/26/20 Raymond James
Adverum Biotechnologies downgradedat Raymond James on abicipar CRL
06/26/20 Raymond James
Adverum Biotechnologies downgraded to Underperform at Raymond James
ADVM Adverum Biotechnologies
$19.90 /

-1.18 (-5.60%)

  • 12
    Feb
ADVM Adverum Biotechnologies
$19.90 /

-1.18 (-5.60%)

Recommendations
Misonix price target raised to $23 from $18 at Craig-Hallum » 08:36
07/13/20
07/13
08:36
07/13/20
08:36
MSON

Misonix

$14.09 /

+3.2 (+29.38%)

Craig-Hallum analyst Alex…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MSON Misonix
$14.09 /

+3.2 (+29.38%)

MSON Misonix
$14.09 /

+3.2 (+29.38%)

04/03/20 Craig-Hallum
Misonix price target lowered to $18 from $28 at Craig-Hallum
04/03/20 BTIG
Misonix price target lowered to $18 from $27 at BTIG
12/31/19 Craig-Hallum
Misonix's amended credit line removes capital needs questions, says Craig-Hallum
08/15/19 Canaccord
Misonix price target raised to $30 from $24 at Canaccord
MSON Misonix
$14.09 /

+3.2 (+29.38%)

  • 23
    Jan
Hot Stocks
Wrap Technologies to train seven new agencies on BolaWrap in Maryland » 08:35
07/13/20
07/13
08:35
07/13/20
08:35
WRTC

Wrap Technologies

$12.22 /

-0.11 (-0.89%)

Wrap Technologies is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WRTC Wrap Technologies
$12.22 /

-0.11 (-0.89%)

WRTC Wrap Technologies
$12.22 /

-0.11 (-0.89%)

07/06/20 Northland
Wrap Technologies downgraded to Market Perform from Outperform at Northland
03/24/20 Northland
Wrap Technologies upgraded to Outperform from Market Perform at Northland
01/29/20 Ladenburg
Wrap Technologies initiated with a Buy at Ladenburg
01/29/20 Ladenburg
Wrap Technologies initiated with a Buy at Ladenburg
WRTC Wrap Technologies
$12.22 /

-0.11 (-0.89%)

Hot Stocks
Enzo Biochem receives EUA for test system for detection of SARS-CoV-2 » 08:35
07/13/20
07/13
08:35
07/13/20
08:35
ENZ

Enzo Biochem

$2.85 /

+0.15 (+5.56%)

Enzo Biochem announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENZ Enzo Biochem
$2.85 /

+0.15 (+5.56%)

Hot Stocks
T. Rowe Price reports preliminary AUM $1.22T at June 30 » 08:34
07/13/20
07/13
08:34
07/13/20
08:34
TROW

T. Rowe Price

$127.32 /

+4.49 (+3.66%)

Client transfers from…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TROW T. Rowe Price
$127.32 /

+4.49 (+3.66%)

TROW T. Rowe Price
$127.32 /

+4.49 (+3.66%)

06/29/20 BMO Capital
T. Rowe Price price target raised to $128 from $109 at BMO Capital
06/15/20 Barclays
T. Rowe Price price target raised to $110 from $100 at Barclays
04/29/20 Wells Fargo
T. Rowe Price price target raised to $125 from $115 at Wells Fargo
04/29/20 BMO Capital
T. Rowe Price price target raised to $92 from $86 at BMO Capital
TROW T. Rowe Price
$127.32 /

+4.49 (+3.66%)

TROW T. Rowe Price
$127.32 /

+4.49 (+3.66%)

TROW T. Rowe Price
$127.32 /

+4.49 (+3.66%)

Hot Stocks
Syneos Health signs service agreement with Pfizer » 08:33
07/13/20
07/13
08:33
07/13/20
08:33
SYNH

Syneos Health

$56.41 /

+0.17 (+0.30%)

, PFE

Pfizer

$33.84 /

+0.39 (+1.17%)

Syneos Health (SYNH)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SYNH Syneos Health
$56.41 /

+0.17 (+0.30%)

PFE Pfizer
$33.84 /

+0.39 (+1.17%)

SYNH Syneos Health
$56.41 /

+0.17 (+0.30%)

04/03/20 Mizuho
Syneos Health price target lowered to $42 from $56 at Mizuho
04/02/20 Credit Suisse
Syneos Health price target lowered to $62 from $72 at Credit Suisse
03/30/20 Goldman Sachs
Syneos Health downgraded to Neutral from Buy at Goldman Sachs
03/17/20 SunTrust
SunTrust cuts price targets across CROs, downgrades MedPace
PFE Pfizer
$33.84 /

+0.39 (+1.17%)

07/08/20 Piper Sandler
Opko Health price target raised to $6 from $4 at Piper Sandler
07/08/20 Argus
Pfizer positioned for stronger revenue growth in 2021 and beyond, says Argus
07/07/20 Needham
Vaxcyte initiated with a Buy at Needham
07/02/20 B. Riley FBR
Novavax should be bought on weakness from Pfizer data, says B. Riley FBR
SYNH Syneos Health
$56.41 /

+0.17 (+0.30%)

PFE Pfizer
$33.84 /

+0.39 (+1.17%)

SYNH Syneos Health
$56.41 /

+0.17 (+0.30%)

PFE Pfizer
$33.84 /

+0.39 (+1.17%)

PFE Pfizer
$33.84 /

+0.39 (+1.17%)

PFE Pfizer
$33.84 /

+0.39 (+1.17%)

Earnings
Lazydays reports preliminary Q2 revenue $214M, one estimate $181M » 08:33
07/13/20
07/13
08:33
07/13/20
08:33
LAZY

Lazydays

$10.03 /

+1.375 (+15.89%)

Reports preliminary Q2…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LAZY Lazydays
$10.03 /

+1.375 (+15.89%)

LAZY Lazydays
$10.03 /

+1.375 (+15.89%)

06/30/20 Craig-Hallum
Lazydays continues geographic expansion with 'sizeable' deal, says Craig-Hallum
06/11/20 Craig-Hallum
Lazydays price target raised to $12 from $7 at Craig-Hallum
06/10/20 Craig-Hallum
Lazydays price target raised to $12 from $7 at Craig-Hallum
LAZY Lazydays
$10.03 /

+1.375 (+15.89%)

Hot Stocks
Net Element amends merger LOI with Mullen to extend exclusivity period » 08:33
07/13/20
07/13
08:33
07/13/20
08:33
NETE

Net Element

$11.54 /

+0.94 (+8.87%)

Net Element provides an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NETE Net Element
$11.54 /

+0.94 (+8.87%)

Hot Stocks
Citi enters alliance with BlackRock for securities services for mutual clients » 08:33
07/13/20
07/13
08:33
07/13/20
08:33
C

Citi

$52.64 /

+3.205 (+6.48%)

, BLK

BlackRock

$554.82 /

+5.27 (+0.96%)

Citi (C) has entered into…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
C Citi
$52.64 /

+3.205 (+6.48%)

BLK BlackRock
$554.82 /

+5.27 (+0.96%)

C Citi
$52.64 /

+3.205 (+6.48%)

07/08/20 Seaport Global
Citi initiated with a Buy at Seaport Global
07/07/20 Societe Generale
Societe Generale upgrades BofA, Citi to Buy on 'path to respectability'
07/07/20 Societe Generale
Citi upgraded to Buy from Hold at Societe Generale
07/01/20 BofA
BofA makes 14 additions, four deletions from US 1 list
BLK BlackRock
$554.82 /

+5.27 (+0.96%)

06/15/20 Barclays
BlackRock price target raised to $580 from $515 at Barclays
06/02/20 Wells Fargo
BlackRock price target raised to $605 from $530 at Wells Fargo
05/14/20 Wells Fargo
BlackRock price target raised to $530 from $495 at Wells Fargo
05/12/20 Stephens
PNC Financial upgraded to Overweight from Equal Weight at Stephens
C Citi
$52.64 /

+3.205 (+6.48%)

BLK BlackRock
$554.82 /

+5.27 (+0.96%)

  • 13
    May
C Citi
$52.64 /

+3.205 (+6.48%)

BLK BlackRock
$554.82 /

+5.27 (+0.96%)

C Citi
$52.64 /

+3.205 (+6.48%)

BLK BlackRock
$554.82 /

+5.27 (+0.96%)

C Citi
$52.64 /

+3.205 (+6.48%)

BLK BlackRock
$554.82 /

+5.27 (+0.96%)

C Citi
$52.64 /

+3.205 (+6.48%)

Hot Stocks
Celsion says IDMC recommends considering stopping Phase III OPTIMA study » 08:32
07/13/20
07/13
08:32
07/13/20
08:32
CLSN

Celsion

$3.56 /

-0.1 (-2.73%)

Celsion announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLSN Celsion
$3.56 /

-0.1 (-2.73%)

CLSN Celsion
$3.56 /

-0.1 (-2.73%)

CLSN Celsion
$3.56 /

-0.1 (-2.73%)

Conference/Events
National Press Club hosts a virtual event » 08:31
07/13/20
07/13
08:31
07/13/20
08:31

Federal Reserve Bank of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Study points to possible role for Rigel in treating COVID injury, says Citi » 08:30
07/13/20
07/13
08:30
07/13/20
08:30
RIGL

Rigel Pharmaceuticals

$1.78 /

-0.04 (-2.20%)

Citi analyst Yigal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RIGL Rigel Pharmaceuticals
$1.78 /

-0.04 (-2.20%)

RIGL Rigel Pharmaceuticals
$1.78 /

-0.04 (-2.20%)

02/27/20 Piper Sandler
Piper Sandler continues to like Rigel Pharmaceuticals setup
01/16/20 H.C. Wainwright
Rigel launch of Tavalisse remains encouraging, says H.C. Wainwright
01/13/20 Piper Sandler
Rigel still one of the most under-appreciated stories in sector, says Piper
11/15/19
Fly Intel: Top five analyst initiations
RIGL Rigel Pharmaceuticals
$1.78 /

-0.04 (-2.20%)

RIGL Rigel Pharmaceuticals
$1.78 /

-0.04 (-2.20%)

Recommendations
Ping Identity price target raised to $36 from $32 at RBC Capital » 08:30
07/13/20
07/13
08:30
07/13/20
08:30
PING

Ping Identity

$33.97 /

+0.59 (+1.77%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PING Ping Identity
$33.97 /

+0.59 (+1.77%)

PING Ping Identity
$33.97 /

+0.59 (+1.77%)

07/07/20 Wells Fargo
Ping Identity price target raised to $35 from $30 at Wells Fargo
07/07/20 Oppenheimer
Ping Identity price target raised to $35 from $26 at Oppenheimer
06/24/20
Fly Intel: Top five analyst initiations
06/24/20 Baird
Ping Identity initiated with a Neutral at Baird
PING Ping Identity
$33.97 /

+0.59 (+1.77%)

  • 09
    Jul
  • 14
    May
  • 19
    Sep
PING Ping Identity
$33.97 /

+0.59 (+1.77%)

Options
Two new option listings and one option delisting on July 13th » 08:30
07/13/20
07/13
08:30
07/13/20
08:30
ADCT

ADC Therapeutics

$43.84 /

+0.31 (+0.71%)

, AVNT

Avant!

$25.40 /

+1.03 (+4.23%)

, POL

PolyOne

$0.00 /

+ (+0.00%)

New option listings for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADCT ADC Therapeutics
$43.84 /

+0.31 (+0.71%)

POL PolyOne
$0.00 /

+ (+0.00%)

ADCT ADC Therapeutics
$43.84 /

+0.31 (+0.71%)

06/09/20 Morgan Stanley
ADC Therapeutics initiated with an Overweight at Morgan Stanley
06/09/20 Cowen
ADC Therapeutics initiated with an Outperform at Cowen
06/09/20 BofA
ADC Therapeutics initiated with a Buy at BofA
06/09/20 BofA
ADC Therapeutics initiated with a Buy at BofA
AVNT Avant!
$25.40 /

+1.03 (+4.23%)

POL PolyOne
$0.00 /

+ (+0.00%)

07/02/20 Baird
PolyOne price target raised to $30 from $25 at Baird
06/16/20 Stifel
PolyOne downgraded to Hold on limited near-term upside at Stifel
06/16/20 Stifel
PolyOne downgraded to Hold from Buy at Stifel
05/28/20
Fly Intel: Top five analyst initiations
POL PolyOne
$0.00 /

+ (+0.00%)

  • 15
    May
  • 31
    Jan
  • 03
    Oct
Conference/Events
Federal Reserve Bank of NY and Bank of England to hold a webinar » 08:29
07/13/20
07/13
08:29
07/13/20
08:29

The Bank of England and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Ballard Power price target raised to $25 from $20 at Roth Capital » 08:29
07/13/20
07/13
08:29
07/13/20
08:29
BLDP

Ballard Power

$20.50 /

-0.25 (-1.20%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BLDP Ballard Power
$20.50 /

-0.25 (-1.20%)

BLDP Ballard Power
$20.50 /

-0.25 (-1.20%)

07/06/20 National Bank
Ballard Power initiated with a Sector Perform at National Bank
06/29/20 Roth Capital
Ballard Power upgraded to Buy at Roth Capital
06/29/20 Roth Capital
Ballard Power upgraded to Buy from Neutral at Roth Capital
06/18/20 TD Securities
Ballard Power initiated with a Hold at TD Securities
BLDP Ballard Power
$20.50 /

-0.25 (-1.20%)

BLDP Ballard Power
$20.50 /

-0.25 (-1.20%)

Recommendations
Workhorse Group price target raised to $27 from $12 at Roth Capital » 08:25
07/13/20
07/13
08:25
07/13/20
08:25
WKHS

Workhorse Group

$15.18 /

-0.88 (-5.48%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WKHS Workhorse Group
$15.18 /

-0.88 (-5.48%)

WKHS Workhorse Group
$15.18 /

-0.88 (-5.48%)

07/09/20
Fly Intel: Top five analyst downgrades
07/09/20 Colliers
Workhorse Group downgraded to Neutral from Buy at Colliers
07/09/20 Colliers
Workhorse Group downgraded to Neutral from Buy at Colliers
07/01/20 BTIG
Workhorse Group price target raised to $26 from $10 at BTIG
WKHS Workhorse Group
$15.18 /

-0.88 (-5.48%)

WKHS Workhorse Group
$15.18 /

-0.88 (-5.48%)

WKHS Workhorse Group
$15.18 /

-0.88 (-5.48%)

WKHS Workhorse Group
$15.18 /

-0.88 (-5.48%)

Technical Analysis
DJ Transportation Average: Pivot points » 08:25
07/13/20
07/13
08:25
07/13/20
08:25
$DJT

DJ Transportation Average

$0.00 /

+ (+0.00%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$DJT DJ Transportation Average
$0.00 /

+ (+0.00%)

$DJT DJ Transportation Average
$0.00 /

+ (+0.00%)

Technical Analysis
DJ Utility Average: Pivot points » 08:24
07/13/20
07/13
08:24
07/13/20
08:24
$DJU

DJ Utility Average

$0.00 /

+ (+0.00%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$DJU DJ Utility Average
$0.00 /

+ (+0.00%)

Downgrade
ViacomCBS downgraded to Neutral from Buy at BofA » 08:24
07/13/20
07/13
08:24
07/13/20
08:24
VIAC

ViacomCBS

$22.94 /

+0.83 (+3.75%)

BofA analyst Jessica…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VIAC ViacomCBS
$22.94 /

+0.83 (+3.75%)

VIAC ViacomCBS
$22.94 /

+0.83 (+3.75%)

05:05 Today Goldman Sachs
ViacomCBS initiated with a Buy at Goldman Sachs
06/26/20 Needham
ViacomCBS price target raised to $30 from $20 at Needham
06/23/20 Citi
ViacomCBS price target raised to $27 from $20 at Citi
06/19/20 Macquarie
ViacomCBS price target raised to $26 from $18 at Macquarie
VIAC ViacomCBS
$22.94 /

+0.83 (+3.75%)

VIAC ViacomCBS
$22.94 /

+0.83 (+3.75%)

VIAC ViacomCBS
$22.94 /

+0.83 (+3.75%)

VIAC ViacomCBS
$22.94 /

+0.83 (+3.75%)

Recommendations
Varonis price target raised to $120 from $110 at Needham » 08:24
07/13/20
07/13
08:24
07/13/20
08:24
VRNS

Varonis

$101.19 /

-1.75 (-1.70%)

Needham analyst Alex…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRNS Varonis
$101.19 /

-1.75 (-1.70%)

VRNS Varonis
$101.19 /

-1.75 (-1.70%)

07/07/20 RBC Capital
Varonis price target raised to $115 from $96 at RBC Capital
07/01/20 JPMorgan
Varonis initiated with an Overweight, added to Focus List at JPMorgan
06/26/20 Wedbush
Varonis price target raised to $110 from $88 at Wedbush
06/26/20 Berenberg
Varonis initiated with a Hold at Berenberg
VRNS Varonis
$101.19 /

-1.75 (-1.70%)

VRNS Varonis
$101.19 /

-1.75 (-1.70%)

Technical Analysis
Dow Jones Industrial Average: Pivot points » 08:24
07/13/20
07/13
08:24
07/13/20
08:24
DJX

Dow Jones Industrial Average

$0.00 /

+ (+0.00%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DJX Dow Jones Industrial Average
$0.00 /

+ (+0.00%)

DJX Dow Jones Industrial Average
$0.00 /

+ (+0.00%)

02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
DJX Dow Jones Industrial Average
$0.00 /

+ (+0.00%)

DJX Dow Jones Industrial Average
$0.00 /

+ (+0.00%)

Technical Analysis
iShares Transportation Average: Pivot points » 08:24
07/13/20
07/13
08:24
07/13/20
08:24
IYT

iShares Transportation Average

$165.06 /

+3.13 (+1.93%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IYT iShares Transportation Average
$165.06 /

+3.13 (+1.93%)

IYT iShares Transportation Average
$165.06 /

+3.13 (+1.93%)

IYT iShares Transportation Average
$165.06 /

+3.13 (+1.93%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.